article thumbnail

JURA Bio and Syena partner to develop TCR-based therapies

Pharmaceutical Technology

JURA Bio has entered into a research collaboration with Replay cell therapy product company Syena for the development of TCR based therapies.

article thumbnail

Kezar and Everest enter lupus nephritis therapy development deal

Pharmaceutical Technology

Kezar and Everest Medicines have signed a deal for the development and commercialisation of zetomipzomib for lupus nephritis.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biostax and Immgenuity to expedite HIV immunotherapies development

Pharmaceutical Technology

Biostax and Immgenuity have entered into an agreement to expedite the development of new immunotherapeutics to treat HIV and other diseases.

article thumbnail

Revive begins development of next-generation Bucillamine formulation

Pharmaceutical Technology

Revive has begun the development of a next-generation formulation of Bucillamine to treat public health emergencies.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies.

article thumbnail

9 Ways Worldwide Optimizes Clinical Development for Your Biotech Growth Journey

Worldwide Clinical Trials

Selecting the right CRO to partner with on your development program is a pivotal decision that can shape the trajectory of your product’s development. You’ll have direct access to our subject matter experts and your counterparts as needed for truly collaborative development. You have the oversight you need.

article thumbnail

Novo Nordisk and Valo to develop cardiometabolic disease therapies

Pharmaceutical Technology

Novo Nordisk has signed an agreement with Valo Health for the discovery and development of new therapies to treat cardiometabolic diseases.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

Learning Objectives: Dose-response curves and patient treatment: How do pharmacologic and toxicologic principles apply to the dosing of drugs in clinical development? Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs.